Healthcare & Medical Investment Corporation
HealthCare & Medical Investment Corporation (Code 3455) January 2027 Operational Status and Distribution Forecast Revisions, and July 2027 Operational Status and Distribution Forecast
Revise operating status forecasts for January 2027 and July 2027. January: operating revenue up by 531 million yen vs previous forecast, operating profit up by 401 million yen, per-share distribution unchanged at 3,440 yen. July: projected operating revenue 3,258 million yen, per-share distribution 2,753 yen. Based on new share issuance plan and funding assumptions, LTV is expected to be around 50%.
Key Figures
- January 2027 Operating Revenue 3,515 million yen (YoY +531 million yen)
- January 2027 Operating Profit 2,051 million yen (YoY +401 million yen)
- January 2027 Net Income Attributable to Owners of Parent 1,625 million yen (YoY +314 million yen)
AI要約
Key changes to earnings outlook
This investment corporation revised its operating outlook for January 2027 and July 2027. January: operating revenue increased by 531 million yen vs the prior forecast, with operating profit, ordinary income, and net income each higher by approximately 314–401 million yen. The per-share distribution remains at 3,440 yen (no excess distribution). For July, considering the impact of new acquisition opportunities, the forecast assumes operating revenue of 3,258 million yen, net income of approximately 1,204–1,205 million yen, and per-share distribution of 3,170 yen.
Capital policy and financial premises
In line with the resolution to issue new investment units and the assumption of new borrowings, the projected end-of-period loan-to-value (LTV) is about 50.9–51.1%. Updated estimates reflect acquisition-related costs, depreciation, repairs, and capital expenditures. A gain on sale of an asset of 344 million yen is expected to be booked in January 2027.
HealthCare & Medical Investment Corporation
Company overview · Stock price · Financial data · All IR
